Pharmacological Effects and Mechanisms of Action of Myricanol
Molecules · 22.05.2026 · 31 (11) · 1781
DOI: 10.3390/molecules31111781 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 22.05.2026. Verfasst von Kai He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Institute, Hunan University of Medicine, Huaihua 418000, China. Hauptthemen laut MEDLINE: Diarylheptanoids, Myrica. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Education Department of Hunan Province, Natural Science Foundation of Hunan Province, Scientific Research Fund of Hunan Provincial Education Department.
Abstract (Originalsprache)
The bark of Myrica rubra (Lour.) Siebold & Zucc (M. rubra) is a natural remedy widely used in China and other Asian countries to treat tissue and bone injuries, burns, scalds, gastrointestinal ulcers, and diarrhea. Myricanol is an important ingredient in the bark of M. rubra. This review summarizes articles published over the past 26 years on the pharmacological effects and mechanisms of action of myricanol, aiming to advance research and applications of myricanol. Evidence shows that myricanol has multiple bioactive properties, including antioxidant, anticancer, anti-inflammatory, antimicrobial, antidiabetic, and antihyperlipidemic effects. Myricanol improves metabolic abnormalities in mice by activating the AMPK/SIRT1/PGC-1α signaling pathway. It also demonstrates significant anticancer, antioxidant, and anti-inflammatory actions, primarily by regulating Caspase and BCL-2 family proteins, inhibiting iNOS expression, scavenging free radicals, and interacting with Peroxiredoxin 5. Therefore, myricanol shows great potential for the treatment of cancer, metabolic abnormalities, and inflammatory bowel disease. Further research is needed to improve its bioavailability, confirm its pharmacological effects and mechanisms in vivo, and explore its pharmacokinetic properties and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Research Institute, Hunan University of Medicine, Huaihua 418000, China.
- CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
ORCID-Profile: Kai He
Förderung
- Education Department of Hunan Province
- Natural Science Foundation of Hunan Province
- Scientific Research Fund of Hunan Provincial Education Department
Zitieren
APA
He, K., Li, H., Sun, H., Li, N., Wang, T., Jiang, J. D., & Peng, Z. G. (2026). Pharmacological Effects and Mechanisms of Action of Myricanol. Molecules, 31(11), 1781. https://doi.org/10.3390/molecules31111781
Vancouver
He K, Li H, Sun H, Li N, Wang T, Jiang JD, et al. Pharmacological Effects and Mechanisms of Action of Myricanol. Molecules. 2026;31(11):1781. doi:10.3390/molecules31111781
BibTeX
@article{He2026,
author = {He, Kai and Li, Hu and Sun, Han and Li, Ning and Wang, Tong and Jiang, Jian-Dong and Peng, Zong-Gen},
title = {Pharmacological Effects and Mechanisms of Action of Myricanol},
journal = {Molecules},
year = {2026},
volume = {31},
number = {11},
pages = {1781},
doi = {10.3390/molecules31111781}
}
EUVIMED